The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Active Implantable Devices-Global Market Insights and Sales Trends 2024
Synopsis
Active implantable medical devices are powered devices that are inserted into a patient’s body, through either a natural orifice or by surgical means, and are intended to remain in the patient’s body after the procedure. Such devices are usually battery powered, and the power supply can either be contained in the instrument or be connected to wires that protrude from the patient’s body.
The global Active Implantable Devices market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Active Implantable Devices in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Active Implantable Devices market. Implantable Cardioverter Defibrillator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Implantable Cardiac Pacemakers segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Active Implantable Devices market, driven by demand from China, the second largest economy with some signs of stabilising, the Active Implantable Devices market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Active Implantable Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Active Implantable Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Active Implantable Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Active Implantable Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Active Implantable Devices covered in this report include LivaNova PLC(U.K.), MED-EL(Austria), Medtronic(Ireland), Abbott Laboratories(U.S.), BIOTRONIK(Germany), Boston Scientific Corporation(U.S.), Cochlear Limited(Australia), Nurotron Biotechnology(China) and Sonova Holding Switzerland), etc.
The global Active Implantable Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
LivaNova PLC(U.K.)
MED-EL(Austria)
Medtronic(Ireland)
Abbott Laboratories(U.S.)
BIOTRONIK(Germany)
Boston Scientific Corporation(U.S.)
Cochlear Limited(Australia)
Nurotron Biotechnology(China)
Sonova Holding Switzerland)
William Demant Holding(Denmark)
Global Active Implantable Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Active Implantable Devices market, Segment by Type:
Implantable Cardioverter Defibrillator
Implantable Cardiac Pacemakers
Ventricular Assist Devices
Implantable Heart Monitors/Insertable Loop Recorders
Neurostimulators
Implantable Hearing Devices
Global Active Implantable Devices market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Active Implantable Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Active Implantable Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Active implantable medical devices are powered devices that are inserted into a patient’s body, through either a natural orifice or by surgical means, and are intended to remain in the patient’s body after the procedure. Such devices are usually battery powered, and the power supply can either be contained in the instrument or be connected to wires that protrude from the patient’s body.
The global Active Implantable Devices market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Active Implantable Devices in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Active Implantable Devices market. Implantable Cardioverter Defibrillator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Implantable Cardiac Pacemakers segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Active Implantable Devices market, driven by demand from China, the second largest economy with some signs of stabilising, the Active Implantable Devices market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Active Implantable Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Active Implantable Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Active Implantable Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Active Implantable Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Active Implantable Devices covered in this report include LivaNova PLC(U.K.), MED-EL(Austria), Medtronic(Ireland), Abbott Laboratories(U.S.), BIOTRONIK(Germany), Boston Scientific Corporation(U.S.), Cochlear Limited(Australia), Nurotron Biotechnology(China) and Sonova Holding Switzerland), etc.
The global Active Implantable Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
LivaNova PLC(U.K.)
MED-EL(Austria)
Medtronic(Ireland)
Abbott Laboratories(U.S.)
BIOTRONIK(Germany)
Boston Scientific Corporation(U.S.)
Cochlear Limited(Australia)
Nurotron Biotechnology(China)
Sonova Holding Switzerland)
William Demant Holding(Denmark)
Global Active Implantable Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Active Implantable Devices market, Segment by Type:
Implantable Cardioverter Defibrillator
Implantable Cardiac Pacemakers
Ventricular Assist Devices
Implantable Heart Monitors/Insertable Loop Recorders
Neurostimulators
Implantable Hearing Devices
Global Active Implantable Devices market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Active Implantable Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Active Implantable Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Active Implantable Devices Market Overview
1.1 Active Implantable Devices Product Overview
1.2 Active Implantable Devices Market Segment by Type
1.2.1 Implantable Cardioverter Defibrillator
1.2.2 Implantable Cardiac Pacemakers
1.2.3 Ventricular Assist Devices
1.2.4 Implantable Heart Monitors/Insertable Loop Recorders
1.2.5 Neurostimulators
1.2.6 Implantable Hearing Devices
1.3 Global Active Implantable Devices Market Size by Type
1.3.1 Global Active Implantable Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Active Implantable Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Active Implantable Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Active Implantable Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Active Implantable Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Active Implantable Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Active Implantable Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Active Implantable Devices Sales Breakdown by Type (2018-2023)
2 Global Active Implantable Devices Market Competition by Company
2.1 Global Top Players by Active Implantable Devices Sales (2018-2023)
2.2 Global Top Players by Active Implantable Devices Revenue (2018-2023)
2.3 Global Top Players by Active Implantable Devices Price (2018-2023)
2.4 Global Top Manufacturers Active Implantable Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Active Implantable Devices Market Competitive Situation and Trends
2.5.1 Active Implantable Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Active Implantable Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Active Implantable Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Active Implantable Devices Market
2.8 Key Manufacturers Active Implantable Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Active Implantable Devices Status and Outlook by Region
3.1 Global Active Implantable Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Active Implantable Devices Historic Market Size by Region
3.2.1 Global Active Implantable Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Active Implantable Devices Sales in Value by Region (2018-2023)
3.2.3 Global Active Implantable Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Active Implantable Devices Forecasted Market Size by Region
3.3.1 Global Active Implantable Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Active Implantable Devices Sales in Value by Region (2024-2029)
3.3.3 Global Active Implantable Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Active Implantable Devices by Application
4.1 Active Implantable Devices Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Active Implantable Devices Market Size by Application
4.2.1 Global Active Implantable Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Active Implantable Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Active Implantable Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Active Implantable Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Active Implantable Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Active Implantable Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Active Implantable Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Active Implantable Devices Sales Breakdown by Application (2018-2023)
5 North America Active Implantable Devices by Country
5.1 North America Active Implantable Devices Historic Market Size by Country
5.1.1 North America Active Implantable Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Active Implantable Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Active Implantable Devices Sales in Value by Country (2018-2023)
5.2 North America Active Implantable Devices Forecasted Market Size by Country
5.2.1 North America Active Implantable Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Active Implantable Devices Sales in Value by Country (2024-2029)
6 Europe Active Implantable Devices by Country
6.1 Europe Active Implantable Devices Historic Market Size by Country
6.1.1 Europe Active Implantable Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Active Implantable Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Active Implantable Devices Sales in Value by Country (2018-2023)
6.2 Europe Active Implantable Devices Forecasted Market Size by Country
6.2.1 Europe Active Implantable Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Active Implantable Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Active Implantable Devices by Region
7.1 Asia-Pacific Active Implantable Devices Historic Market Size by Region
7.1.1 Asia-Pacific Active Implantable Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Active Implantable Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Active Implantable Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Active Implantable Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Active Implantable Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Active Implantable Devices Sales in Value by Region (2024-2029)
8 Latin America Active Implantable Devices by Country
8.1 Latin America Active Implantable Devices Historic Market Size by Country
8.1.1 Latin America Active Implantable Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Active Implantable Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Active Implantable Devices Sales in Value by Country (2018-2023)
8.2 Latin America Active Implantable Devices Forecasted Market Size by Country
8.2.1 Latin America Active Implantable Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Active Implantable Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Active Implantable Devices by Country
9.1 Middle East and Africa Active Implantable Devices Historic Market Size by Country
9.1.1 Middle East and Africa Active Implantable Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Active Implantable Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Active Implantable Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Active Implantable Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Active Implantable Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Active Implantable Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 LivaNova PLC(U.K.)
10.1.1 LivaNova PLC(U.K.) Company Information
10.1.2 LivaNova PLC(U.K.) Introduction and Business Overview
10.1.3 LivaNova PLC(U.K.) Active Implantable Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 LivaNova PLC(U.K.) Active Implantable Devices Products Offered
10.1.5 LivaNova PLC(U.K.) Recent Development
10.2 MED-EL(Austria)
10.2.1 MED-EL(Austria) Company Information
10.2.2 MED-EL(Austria) Introduction and Business Overview
10.2.3 MED-EL(Austria) Active Implantable Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 MED-EL(Austria) Active Implantable Devices Products Offered
10.2.5 MED-EL(Austria) Recent Development
10.3 Medtronic(Ireland)
10.3.1 Medtronic(Ireland) Company Information
10.3.2 Medtronic(Ireland) Introduction and Business Overview
10.3.3 Medtronic(Ireland) Active Implantable Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Medtronic(Ireland) Active Implantable Devices Products Offered
10.3.5 Medtronic(Ireland) Recent Development
10.4 Abbott Laboratories(U.S.)
10.4.1 Abbott Laboratories(U.S.) Company Information
10.4.2 Abbott Laboratories(U.S.) Introduction and Business Overview
10.4.3 Abbott Laboratories(U.S.) Active Implantable Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Abbott Laboratories(U.S.) Active Implantable Devices Products Offered
10.4.5 Abbott Laboratories(U.S.) Recent Development
10.5 BIOTRONIK(Germany)
10.5.1 BIOTRONIK(Germany) Company Information
10.5.2 BIOTRONIK(Germany) Introduction and Business Overview
10.5.3 BIOTRONIK(Germany) Active Implantable Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 BIOTRONIK(Germany) Active Implantable Devices Products Offered
10.5.5 BIOTRONIK(Germany) Recent Development
10.6 Boston Scientific Corporation(U.S.)
10.6.1 Boston Scientific Corporation(U.S.) Company Information
10.6.2 Boston Scientific Corporation(U.S.) Introduction and Business Overview
10.6.3 Boston Scientific Corporation(U.S.) Active Implantable Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Boston Scientific Corporation(U.S.) Active Implantable Devices Products Offered
10.6.5 Boston Scientific Corporation(U.S.) Recent Development
10.7 Cochlear Limited(Australia)
10.7.1 Cochlear Limited(Australia) Company Information
10.7.2 Cochlear Limited(Australia) Introduction and Business Overview
10.7.3 Cochlear Limited(Australia) Active Implantable Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Cochlear Limited(Australia) Active Implantable Devices Products Offered
10.7.5 Cochlear Limited(Australia) Recent Development
10.8 Nurotron Biotechnology(China)
10.8.1 Nurotron Biotechnology(China) Company Information
10.8.2 Nurotron Biotechnology(China) Introduction and Business Overview
10.8.3 Nurotron Biotechnology(China) Active Implantable Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Nurotron Biotechnology(China) Active Implantable Devices Products Offered
10.8.5 Nurotron Biotechnology(China) Recent Development
10.9 Sonova Holding Switzerland)
10.9.1 Sonova Holding Switzerland) Company Information
10.9.2 Sonova Holding Switzerland) Introduction and Business Overview
10.9.3 Sonova Holding Switzerland) Active Implantable Devices Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sonova Holding Switzerland) Active Implantable Devices Products Offered
10.9.5 Sonova Holding Switzerland) Recent Development
10.10 William Demant Holding(Denmark)
10.10.1 William Demant Holding(Denmark) Company Information
10.10.2 William Demant Holding(Denmark) Introduction and Business Overview
10.10.3 William Demant Holding(Denmark) Active Implantable Devices Sales, Revenue and Gross Margin (2018-2023)
10.10.4 William Demant Holding(Denmark) Active Implantable Devices Products Offered
10.10.5 William Demant Holding(Denmark) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Active Implantable Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Active Implantable Devices Industrial Chain Analysis
11.4 Active Implantable Devices Market Dynamics
11.4.1 Active Implantable Devices Industry Trends
11.4.2 Active Implantable Devices Market Drivers
11.4.3 Active Implantable Devices Market Challenges
11.4.4 Active Implantable Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Active Implantable Devices Distributors
12.3 Active Implantable Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
